Rapid Therapeutic Science Laboratories, Inc.
OTC: RTSL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Donal R. Schmidt Jr.
- Employees
- 3
- Headquarters
- Dallas, United States
- IPO year
- 2017
- Market cap
- $883.0
- Website
- https://www.rtslco.com
Loading RTSL…
Loading profile data…Frequently asked questions about RTSL
What does Rapid Therapeutic Science Laboratories, Inc. (RTSL) do?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recov...
Where does RTSL trade?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) trades on the Other OTC.
What sector is RTSL in?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Rapid Therapeutic Science Laboratories, Inc.?
Donal R. Schmidt Jr. is the chief executive officer of Rapid Therapeutic Science Laboratories, Inc. (RTSL).
Where is Rapid Therapeutic Science Laboratories, Inc. headquartered?
Rapid Therapeutic Science Laboratories, Inc. is headquartered in United States.
Does RTSL pay a dividend?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RTSL go public?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) completed its initial public offering in 2017.